pdf

O’Melveny works with corporate and investor clients to design and execute M&A programs that achieve strategic growth and critical financial objectives. True partners to our clients throughout the process, we go well beyond negotiating and structuring deals to add tangible business value. That means vetting financial advisors, introducing financing options, and leveraging our considerable professional network to generate opportunities and dealflow for clients.

Our practice is built to serve clients, offering a strong international platform with experienced lawyers on both coasts of the US, as well as in key commercial centers in Asia and Europe. In addition, we provide deep knowledge of industry issues, including in the technology, entertainment and media, energy, infrastructure, industrials, and consumer sectors. The result is the right kind of support our clients need as they pursue growth opportunities, wherever those opportunities may arise.

    • Our highly active team regularly ranks among the top firms in league tables published by Bloomberg, Mergermarket, Mergerstat, and ThomsonReuters.

    • Our lawyers possess fluency in the full range of M&A-related activities, from acquisitions and divestitures to growth investments, leveraged acquisitions, private equity buyouts, take-privates, carve-outs and spin-offs, joint ventures, and seasoned counseling in hostile or contested situations (e.g., shareholder activism, takeover defense planning and execution, shareholder rights plans, and strategic boardroom-level counseling).

    • Comprised of experienced deal lawyers resident in key commercial centers in the United States, Asia, and Europe, our team is adept at delivering world-class legal services across cultural, language, and geographic boundaries. 

    • In today’s environment, dealmakers face intricate regulatory requirements, national security concerns, and political considerations. Our team includes lawyers who have held senior positions in the White House, the Department of Commerce, the Department of Labor, the Department of Justice, the Federal Trade Commission, and the Securities and Exchange Commission to help clients successfully navigate these issues.
Broad Strengths

    • Asset purchases and sales
    • Auctions
    • Contested transactions
    • Financial-advisor representations
    • “Going private” transactions
    • Joint ventures
    • Leveraged buyouts
    • Mergers
    • Proxy contests
    • Recapitalizations
    • Spin-offs and split-offs
    • Stock purchases and sales
    • Takeover preparedness and advice
    • Tender offers

ADC & HAS Airports Worldwide

An interdisciplinary team of O’Melveny lawyers represented US-based ADC & HAS Airports Worldwide in its acquisition of Northern Ireland’s Belfast International Airport. Read

Apollo Global Management

O’Melveny provided diligence and documentation services to Apollo in connection with its US$875 million acquisition of Regional Care Hospital Partners from Warburg Pincus. Apollo’s investment will finance Regional Care’s plans to develop and further expand its network of hospitals in non-urban areas. Read

Avenue Capital

O’Melveny represented Avenue Capital and its managed funds as an investor in a US$350 million private placement of shares in Euronav NV, an international shipping company focused on sea-borne crude oil transportation.  Read

BB&T Corporation

O’Melveny advised BB&T Corporation in connection with its agreement to acquire National Penn Bancshares, Inc. in a cash and stock transaction for total consideration valued at approximately US$1.8 billion. Read

BGI-Shenzhen

A multi-office, multi-practice O’Melveny team represented BGI Shenzhen, a China based genomic research and sequencing company, in its US$117.6 million acquisition of Complete Genomics and its successful defense of the transaction against a hostile competing bid. Read

Bristol Industries

O’Melveny represented Bristol, one of the few remaining independent manufacturers in the fastener segment of the aerospace industry, in its US$335 million acquisition by Consolidated Aerospace Manufacturing, LLC. O’Melveny counseled Bristol from the initial marketing phase through negotiation and closing of the ultimate sale. Read

Chengwei Capital

O’Melveny represented Chengwei Capital as the main shareholder in Youku Tudou Inc., a leading multi-screen entertainment and media company in China, in Youku Tudou’s definitive agreement to merge an affiliate of Alibaba Group. Read

CoreLogic, Inc.

O’Melveny represented CoreLogic, a global property information, analytics, and data-enabled services provider, in the largest strategic acquisition in its history. Read

Dealertrack Technologies, Inc.

O’Melveny advised Dealertrack Technologies, Inc., a leader in software solutions and services for automotive retailers, in its US$4 billion sale to Cox Automotive, Inc. Read

Exar Corp.

O’Melveny has represented Exar, a New York Stock Exchange-listed supplier of high-performance integrated circuits and system solutions, in more than a dozen acquisitions over the years, including its acquisition of Integrated Memory Logic Limited, a fabless semiconductor company organized as a Cayman Islands exempted company and listed on the Taiwan Stock Exchange. Read

Giant Interactive

O’Melveny successfully defended Giant Interactive, one of China’s leading online game developers and operators, in a shareholder class action seeking to enjoin Giant’s proposed going-private transaction, which O’Melveny also successfully handled.   Read

Giant Interactive

O’Melveny represented Giant Interactive, one of China’s leading online game developers and operators, in its US$3 billion going private transaction. Read

GoGrid

O’Melveny represented GoGrid, a cloud infrastructure service, in its acquisition by Datapipe. Read

Kabam

O’Melveny has advised Kabam, the leader in free-to-play core gaming, in numerous transactions since its establishment in 2006, including all of its venture capital financings and all of its acquisitions. Read

MakerBot

O’Melveny represented MakerBot, a leader in desktop 3D printing, in its acquisition by Stratasys Ltd. Read

Microsemi Corporation

O’Melveny has played a critical role in Microsemi’s growth, having handled some 15 deals for the chipmaker over the past eight years, including its successful US$2.5 billion cash-and-stock “deal jump” to acquire PMC-Sierra and its recent definitive agreement to divest a component of a board level systems and packaging business to Mercury Systems, Inc. for US$300 million. Read

Moelis & Co.

O’Melveny served as counsel to Moelis, financial advisor to Dentsply International in its US$5.5 billion merger with Sirona Dental Systems—a merger that creates the world’s largest maker of dental products. Read

Phoenix Education Publishing Co.

O’Melveny represented Chinese media and publishing company Phoenix Education in its acquisition of children’s book business of Illinois-based Publication International Ltd. (PIL). Read

Samsung Electronics Co. Ltd.

O’Melveny represented Samsung Electronics Co. Ltd. in its acquisition of NeuroLogica Corp., a medical imaging company. Read

Sequoia Capital and China Broadband Capital

O’Melveny represented Sequoia Capital and China Broadband Capital in forming a joint venture with LinkedIn to launch LinkedIn’s China operations, bringing the world’s largest social media platform for professionals to China. Read

Silevo

O’Melveny represented Silevo, a solar photovoltaic cell technology innovator that manufactures high-efficiency, high-performance solar modules, in its acquisition by Elon Musk’s SolarCity Corporation. Read

Skyworks Solutions, Inc.

O’Melveny acted as lead counsel to Skyworks in its US$148.5 million acquisition of a controlling interest in Panasonic Corporation’s filter technology business for smart phones and other mobile applications. Read

Warner Bros.

O’Melveny represented Warner Bros. in its acquisition of Netherlands-based TV producer Eyeworks’ businesses outside the US, comprising holdings throughout 15 territories across Europe, South America, Australia, and New Zealand. Read

WuXi PharmaTech

O’Melveny represented NYSE-listed WuXi PharmaTech (Cayman) Inc., a leading technology company serving the pharmaceutical, biotechnology, and medical device industries in the US and China, in its merger with a group of private equity investors and the company’s founders in a going-private transaction valued at US$3.3 billion. Read
    • Alibaba
    • Apollo Global Management
    • Avenue Capital
    • CA Technologies
    • DealerTrack Technologies
    • GIC
    • Goldman Sachs
    • Honeywell International
    • MHR Fund Management
    • Microsemi Corporation
    • Steel River Infrastructure Partners
    • Warner Bros.